
Please try another search
Investing.com -- AstraZeneca's (ST:AZN) rare disease unit Alexion (NASDAQ:ALXN) said its experimental drug anselamimab failed to meet the main goal in a major late-stage trial for patients with a...
AstraZeneca PLC (LON:AZN) (LSE:AZN, STO:AZN, NASDAQ:AZN) announced Monday that its issued share capital with voting rights stands at 1,550,670,668 ordinary shares of $0.25 each as of June 30, 2025....
Investing.com -- Shares of AstraZeneca (ST:AZN) and GlaxoSmithKline (LON:GSK) fell on Wednesday after U.S. President Donald Trump said tariffs on imported drugs could be imposed “very...
AstraZeneca PLC (LSE/STO/Nasdaq:LON:AZN), the global biopharmaceutical company, has announced a strategic collaboration with CSPC Pharmaceuticals Group Limited, a company based in Shijiazhuang City,...
Investing.com -- AstraZeneca PLC (LON:AZN) has entered into a collaboration agreement with CSPC Pharmaceutical (TADAWUL:2070) Group to advance the discovery of novel oral drug candidates, according...
LONDON/SHIJIAZHUANG - AstraZeneca PLC (LSE:LON:AZN) has entered into a strategic research collaboration with China-based CSPC Pharmaceuticals Group Limited to develop novel oral drug candidates using...
AstraZeneca PLC (LSE/STO/Nasdaq:LON:AZN) disclosed in a recent SEC filing that its Chief Financial Officer, Aradhana Sarin, has donated 200 American Depositary Shares (ADSs) to charity. The...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review